Abstract
A series of compounds was designed as dual inhibitors of the H(3) receptor and the norepinephrine transporter. Compound 5 (rNET K(i) = 14 nM; rH(3)R K(i) = 37 nM) was found to be efficacious in a rat model of osteoarthritic pain.
MeSH terms
-
Animals
-
Histamine H3 Antagonists / chemical synthesis*
-
Histamine H3 Antagonists / pharmacokinetics
-
Histamine H3 Antagonists / pharmacology
-
Naphthols / chemical synthesis*
-
Naphthols / pharmacokinetics
-
Naphthols / pharmacology
-
Norepinephrine Plasma Membrane Transport Proteins / antagonists & inhibitors*
-
Osteoarthritis / drug therapy
-
Pain / drug therapy*
-
Pyrrolidines / chemical synthesis*
-
Pyrrolidines / pharmacokinetics
-
Pyrrolidines / pharmacology
-
Rats
-
Rats, Sprague-Dawley
-
Structure-Activity Relationship
Substances
-
4-(3-(methylamino)-1-phenylpropyl)-6-(2-(pyrrolidin-1-yl)ethoxy)naphthalen-1-ol
-
Histamine H3 Antagonists
-
Naphthols
-
Norepinephrine Plasma Membrane Transport Proteins
-
Pyrrolidines